AWS re:Invent 2019 – Daphne Koller of insitro Talks About Using AWS to Transform Drug Development

8 164
30.6
Опубликовано 16 декабря 2019, 16:50
Learn more about AWS Machine Learning at amzn.to/2PIjo4n.
insitro is working to reinvent drug development, making it faster and less expensive. Leveraging machine learning on AWS, insitro is able to analyze massive amounts of high-content biological data in days rather than months, increasing the productivity of the drug development process. As a result, the company is helping usher in the era of digital biology when insitro will be able to measure biology at unprecedented precision and scale using machine learning—and change human health.
автотехномузыкадетское